ALKEM

Alkem Laboratories Share Price

 

 

Invest in Alkem Laboratories with 3.77X leverage

Invest with MTF

Performance

  • Low
  • ₹5,733
  • High
  • ₹5,833
  • 52 Week Low
  • ₹4,492
  • 52 Week High
  • ₹5,934
  • Open Price₹5,750
  • Previous Close₹5,751
  • Volume84,505
  • 50 DMA₹5,666.93
  • 100 DMA₹5,581.85
  • 200 DMA₹5,448.89

Investment Returns

  • Over 1 Month + 0.22%
  • Over 3 Month + 2.52%
  • Over 6 Month + 21.99%
  • Over 1 Year + 12.82%

Smart Investing Starts Here Start SIP with Alkem Laboratories for Steady Growth!

Invest Now

Alkem Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 29.4
  • PEG Ratio
  • 2.6
  • Market Cap Cr
  • 69,485
  • P/B Ratio
  • 5.2
  • Average True Range
  • 130.9
  • EPS
  • 196.58
  • Dividend Yield
  • 0.8
  • MACD Signal
  • 5.63
  • RSI
  • 58.84
  • MFI
  • 51.2

Alkem Laboratories Financials

Alkem Laboratories Technicals

EMA & SMA

Current Price
₹5,811.50
+ 61 (1.06%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹5,698.83
  • 50 Day
  • ₹5,666.93
  • 100 Day
  • ₹5,581.85
  • 200 Day
  • ₹5,448.89

Resistance and Support

5792.5 Pivot Speed
  • R3 5,952.00
  • R2 5,892.50
  • R1 5,852.00
  • S1 5,752.00
  • S2 5,692.50
  • S3 5,652.00

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Alkem Laboratories Ltd, is one of India’s largest pharmaceutical companies, known for its leading brands like Clavam and Pan-D. With 21 manufacturing facilities and global presence in over 50 countries, Alkem drives innovation with 500+ scientists across 5 R&D centers.

Alkem Laboratories has an operating revenue of Rs. 13,890.16 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of 19% is great, ROE of 18% is exceptional. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 7% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -2% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Alkem Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-13 Quarterly Results & Interim Dividend
2025-11-13 Quarterly Results
2025-08-12 Quarterly Results
2025-05-29 Audited Results & Final Dividend
2025-02-07 Quarterly Results & Interim Dividend
Date Purpose Remarks
2025-08-08 FINAL Rs.8.00 per share(400%)Final Dividend
2025-02-14 INTERIM Rs.37.00 per share(1850%)Interim Dividend
2024-08-10 FINAL Rs.5.00 per share(250%)Final Dividend
2024-02-17 INTERIM Rs.35.00 per share(1750%)Interim Dividend
2023-08-10 FINAL Rs.10.00 per share(500%)Final Dividend
View Alkem Laboratories Dividend History Arrow

Alkem Laboratories F&O

Alkem Laboratories Shareholding Pattern

51.2%
16.06%
3.96%
9.97%
0%
17.09%
1.72%

About Alkem Laboratories

  • NSE Symbol
  • ALKEM
  • BSE Symbol
  • 539523
  • Managing Director
  • Mr. Sandeep Singh
  • ISIN
  • INE540L01014

Similar Stocks to Alkem Laboratories

Alkem Laboratories FAQs

Alkem Laboratories share price is ₹5,811 As on 11 February, 2026 | 02:38

The Market Cap of Alkem Laboratories is ₹69485.2 Cr As on 11 February, 2026 | 02:38

The P/E ratio of Alkem Laboratories is 29.4 As on 11 February, 2026 | 02:38

The PB ratio of Alkem Laboratories is 5.2 As on 11 February, 2026 | 02:38

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23